US11850182 — Inserter
Method of Use · Assigned to Bayer Oy · Expires 2029-09-14 · 3y remaining
What this patent protects
This patent protects an inserter device for intrauterine systems, specifically designed for use with a product.
USPTO Abstract
The invention relates to an inserter for an intrauterine system, including a handle ( 3 ) having a longitudinal opening ( 8 ) at its first end, the opening ( 8 ) having a longitudinal axis parallel to the longitudinal axis of the inserter, a first end ( 8 a ) and a second end ( 8 b ), a moveable slider ( 5 ) arranged in the longitudinal opening ( 8 ) and having a first end ( 5 a ) and a second end ( 5 b ), a plunger ( 2 ) attached to the handle ( 3 ), an insertion tube ( 6 ) arranged around the plunger ( 2 ) having a first end and a second end, with its second end attached to the slider ( 5 ). The inserter further includes a lock that reversibly locks locking the intrauterine system in relation to the plunger ( 2 ) via a removal string of the intrauterine system, the lock being controllable by the slider ( 5 ) and/or the insertion tube ( 6 ).
Drugs covered by this patent
- Jadelle (LEVONORGESTREL) · Fdn Consumer
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-3819 |
— | Jadelle |
U-3819 |
— | Jadelle |
U-3819 |
— | Jadelle |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.